A research team at the University of Toronto has successfully demonstrated a suite of portable biotech tools that utilize freeze-dried reagents and cell-free protein synthesis to produce high-value biological materials. These low-cost systems enable developers to manufacture vaccines and diagnostics on-site in a single day, removing the need for expensive infrastructure or cold chain logistics. This decentralization of biomanufacturing empowers scientists in resource-limited settings to conduct advanced research and respond to local healthcare needs independently.
Read the full article at Genetic Engineering News
Want to create content about this topic? Use Nemati AI tools to generate articles, social posts, and more.
5
Ali NematiWritten by Ali
